Pulmonary Function FEV1/FVC & COPD GOLD Simulator

Q: Why is 0.7 the FEV1/FVC threshold for COPD?

The GOLD guideline defines obstruction (and therefore COPD) as a post-bronchodilator FEV1/FVC below 0.7. Because the normal lower limit (LLN) drops with age, GLI 2012 also recommends the fifth-percentile (z-score) criterion, but the single 0.7 cut-off has survived because it is easy to apply at the bedside. This tool flags any ratio at or above 0.7 as non-obstructive and any value below 0.7 as COPD, then assigns a GOLD stage (1-4).

Q: How is the COPD GOLD stage determined?

Once COPD is confirmed by FEV1/FVC = 80%, GOLD 2 (moderate) 50-80%, GOLD 3 (severe) 30-50%, GOLD 4 (very severe) < 30%. This tool uses the Knudson 1983 equations multiplied by the GLI 2012 ethnicity factor (Asian 0.94, Caucasian 1.00, African 0.88) to derive predicted FEV1, then assigns the stage automatically.

Q: How can I detect a restrictive defect?

A restrictive pattern shows a reduced FVC with a normal FEV1/FVC ratio (>= 0.7). When FVC % predicted is below 80% and the ratio is normal, the verdict line raises a 'suspected restrictive ventilatory defect' flag. Definite confirmation requires measurement of total lung capacity (TLC, by body plethysmography), and TLC < 80% predicted is diagnostic. Typical causes include interstitial pneumonia, pulmonary fibrosis, neuromuscular disease and chest-wall deformity.

Q: What is bronchodilator reversibility?

After inhaling a short-acting beta-2 agonist (for example, salbutamol 400 microgram), spirometry is repeated 15 minutes later. A rise of FEV1 by at least 12% AND 200 mL is considered positive reversibility, which helps distinguish asthma from COPD and identify ACO (asthma-COPD overlap). This tool expects post-bronchodilator values; reversibility testing must be performed separately at the bedside.

Parameters

Age

year

Height

Sex

Ethnicity

GLI 2012 ethnicity correction factor

Measured FEV1

post-bronchodilator FEV1

Measured FVC

Forced vital capacity

Smoking history

pack-y

packs/day x years (COPD risk)

Results

—

Pred FEV1 (L)

—

Pred FVC (L)

—

FEV1/FVC ratio

—

FEV1 % pred (%)

—

FVC % pred (%)

—

COPD GOLD stage

—

Lung cross-section, bronchial tree & flow-volume loop

Left: lung outline and bronchial tree (the airways narrow during expiration in COPD). Right: forced expiratory flow-volume loop (blue: normal, orange: patient). COPD shows the classic downward concavity ("coved" loop).

Flow-volume loop — normal vs patient

Estimated population share by GOLD stage

Theory & Key Formulas

$$\frac{FEV_1}{FVC} \lt 0.7 \;\Rightarrow\; \text{COPD},\qquad GOLD = f(FEV_1\%\text{predicted})$$

Post-bronchodilator FEV1/FVC < 0.7 defines obstruction (COPD). Severity (GOLD 1-4) is graded by FEV1 % predicted at the 80 / 50 / 30 cut-offs.

$$FEV_{1,\text{pred}}^{\,male} = (0.0395\,H - 0.025\,A - 2.6)\cdot k_e$$

Knudson 1983 equation (male). H: height in cm, A: age in years, k_e: ethnicity factor (Asian 0.94, Caucasian 1.00, African 0.88). The female equation uses different coefficients.

$$\%\text{pred} = \frac{FEV_{1,\text{meas}}}{FEV_{1,\text{pred}}}\times 100,\quad \text{restrictive} \Leftarrow FVC\%\lt 80 \wedge FEV_1/FVC\ge 0.7$$

% predicted ranks severity. A restrictive defect is suspected when FVC is reduced with a normal ratio; confirmation requires TLC measurement.

Pulmonary Function Test — FEV1/FVC and COPD GOLD severity

🙋

During a health check I had to blow as hard as I could into a white mouthpiece called a "spirometer". What exactly is it measuring?

🎓

That is the workhorse of pulmonary function testing. You first inhale to your maximum, then exhale as forcefully and as fast as possible. The volume blown out in the first second is FEV1, and the total volume exhaled is FVC. A healthy person empties more than 70% of FVC in the first second, so when this FEV1/FVC ratio drops below 0.7 it means the airways are too narrow to let air out fast — that is what we call obstruction and, by definition, COPD.

🙋

With the sliders at FEV1 = 2.0 L and FVC = 3.0 L the ratio is 0.67 and the tool reports "GOLD 1 mild". Does the same 2.0 L mean different things at different ages?

🎓

Exactly — that is the whole point of spirometry interpretation. Bigger bodies hold bigger lungs, so absolute litres alone are misleading. We compute a predicted value from age, height, sex and ethnicity, then express the measured value as a percentage of that prediction. The Knudson 1983 and GLI 2012 equations are the two standard sources. For a 170 cm, 60-year-old man the predicted FEV1 is about 2.46 L, so 2.0 L is 81% — GOLD 1. The same 2.0 L for a 150 cm, 80-year-old woman would be 130% of her predicted value, i.e. completely normal.

🙋

I had never heard of the ethnicity factor before. Does an Asian factor of 0.94 mean Japanese lungs are smaller than European lungs?

🎓

For the same height and age, Asian populations have roughly 6% smaller lung volumes than Caucasian populations, and African populations about 12% smaller. The differences come from chest-wall geometry and torso/leg ratio. GLI 2012 corrects for this statistically so that the same reference equation can be used worldwide. In Japan an LMS-based "Japanese reference 2014" is also widely used. This tool uses the GLI-compatible Knudson + ethnicity factor, which lines up well with clinical Vyaire or Chest devices.

🙋

When FVC drops below 80% the verdict line says "suspected restrictive defect". Is that a different disease from COPD?

🎓

Yes — restrictive disease is the opposite story. COPD: airways too narrow, hard to exhale (ratio drops). Restrictive: lungs cannot expand, hard to inhale (FVC drops, ratio stays normal). Typical causes are idiopathic pulmonary fibrosis (IPF), interstitial pneumonia, scleroderma-related lung disease, chest-wall deformity and neuromuscular disease. Spirometry cannot measure TLC, so it stops at "suspected"; definite confirmation needs body plethysmography. Mixed patterns also occur and are particularly tricky. The tool flags this scenario automatically so you know to order the next test.

🙋

What is a dangerous level of "pack-years" of smoking?

🎓

One pack a day for one year equals one pack-year. Above 20 pack-years the risk of COPD rises sharply, and above 40 pack-years many countries cover annual low-dose CT lung-cancer screening by insurance. The default 30 pack-years in this tool is typical for a high-risk COPD case. GOLD strongly recommends spirometry for any patient over 40 with smoking history plus chronic cough, sputum or exertional dyspnoea. Stopping smoking returns the FEV1 decline rate to that of a non-smoker, so showing this result to the patient is an important behavioural intervention.

Frequently asked questions

The GOLD guideline defines obstruction (and therefore COPD) as a post-bronchodilator FEV1/FVC below 0.7. Because the normal lower limit (LLN) drops with age, GLI 2012 also recommends the fifth-percentile (z-score) criterion, but the single 0.7 cut-off has survived because it is easy to apply at the bedside. This tool flags any ratio at or above 0.7 as non-obstructive and any value below 0.7 as COPD, then assigns a GOLD stage (1-4).

Once COPD is confirmed by FEV1/FVC < 0.7, severity is graded by FEV1 % predicted: GOLD 1 (mild) FEV1 ≥ 80%, GOLD 2 (moderate) 50–80%, GOLD 3 (severe) 30–50%, GOLD 4 (very severe) < 30%. This tool uses the Knudson 1983 equations multiplied by the GLI 2012 ethnicity factor (Asian 0.94, Caucasian 1.00, African 0.88) to derive predicted FEV1, then assigns the stage automatically.

A restrictive pattern shows a reduced FVC with a normal FEV1/FVC ratio (≥ 0.7). When FVC % predicted is below 80% and the ratio is normal, the verdict line raises a "suspected restrictive ventilatory defect" flag. Definite confirmation requires measurement of total lung capacity (TLC, by body plethysmography), and TLC < 80% predicted is diagnostic. Typical causes include interstitial pneumonia, pulmonary fibrosis, neuromuscular disease and chest-wall deformity.

After inhaling a short-acting β2 agonist (for example, salbutamol 400 μg), spirometry is repeated 15 minutes later. A rise of FEV1 by at least 12% AND 200 mL is considered positive reversibility, which helps distinguish asthma from COPD and identify ACO (asthma-COPD overlap). This tool expects post-bronchodilator values; reversibility testing must be performed separately at the bedside.

Real-world applications

Outpatient pulmonology: any smoker over 40 with chronic cough, sputum or exertional dyspnoea should undergo spirometry per the GOLD guideline. Vyaire (formerly CardinalHealth) CareFusion, Chest Vmax, Minato Medical AS-507 and the handheld MIR Spirobank are the most common devices. They produce the FEV1/FVC needed to apply the same algorithm as this tool to confirm a COPD stage. Early detection allows LAMA/LABA inhalers and structured smoking-cessation programmes to slow the decline.

Pre-operative assessment and perioperative care: before major thoracic or upper-abdominal surgery (lung resection, oesophagectomy, open-heart surgery) spirometry is mandatory. FEV1 < 1 L or FEV1 % predicted < 40% defines a high risk of post-operative pulmonary complications (PPC). For lung resection, the predicted post-operative FEV1 (ppoFEV1) is estimated and ppoFEV1 < 40% is generally considered inoperable. The numbers from this tool form the first quick step in that risk stratification.

Occupational medicine — pneumoconiosis: workers exposed to asbestos, silica or coal dust are followed annually with spirometry to detect a restrictive (FVC) decline. In Japan's compensation system "predicted FVC < 60%" is one criterion for the most severe PR4 category. Construction, mining and shipbuilding rely on Knudson/GLI-style % predicted values, which are also used in legal decisions.

Exercise physiology and sports medicine: elite marathon runners and swimmers may reach 120-140% of predicted FVC. Exercise-induced bronchoconstriction (EIB), on the other hand, shows normal resting FEV1 but a drop of 10% or more after a standardised exercise challenge — that is not detectable from a resting spirometry like this. Peak-flow meters or exercise-challenge spirometry are required instead.

Common misconceptions and caveats

The first major pitfall is diagnosing COPD on pre-bronchodilator values. Both this tool and the GOLD guideline require post-bronchodilator measurements. Patients with asthma or any reversible obstruction can change FEV1 by 12% or 200 mL after inhalation, so confirming COPD from the pre-value risks over-diagnosis. In practice, give 400 μg salbutamol, wait 15 minutes, repeat the test and feed the post-value into the tool.

Second, the fixed 0.7 cut-off does not fit all ages. The healthy FEV1/FVC ratio actually falls with age, and in the 80s the LLN is around 0.65-0.68. Using 0.7 universally therefore over-diagnoses the elderly and under-diagnoses the young. GLI 2012 recommends an age-specific LLN (z-score < -1.645), and GOLD increasingly suggests reporting both. The tool keeps the 0.7 fixed threshold for bedside convenience; for borderline ratios (0.65-0.75) please re-assess against the LLN.

Finally, reproducibility and effort dependence. The whole result hinges on the patient blowing maximally and emptying the lungs completely. The ATS/ERS standards require at least three manoeuvres whose top two FEV1 and FVC agree within 150 mL — anything less must be repeated. Coughing during the manoeuvre, a leak around the mouthpiece, or expiration shorter than 6 seconds will under-estimate FVC and falsely raise the FEV1/FVC ratio so that an obstructive defect is missed. Always inspect the flow-volume loop shape (sharp rise, smooth descent) before trusting the numbers.

Pulmonary Function FEV1/FVC & COPD GOLD Simulator

Pulmonary Function Test — FEV1/FVC and COPD GOLD severity

Frequently asked questions

Real-world applications

Common misconceptions and caveats

How to Use

Worked Example

Practical Notes